Articles & Analysis
Week of 2026-W02
Business Post Weekly Intelligence Briefing
Week of 8–14 January 2026: Key Stories, Official Records & Cross-Domain Insights
Source: ARTICLES | Period: 2026-01-08 to 2026-01-14
Ireland opens 2026 with a banking takeover bid, two unicorn moments, and a Guinness price hike — a week that set the tone for the year ahead
The first full working week of 2026 delivered a concentrated burst of deal activity, distress signals, and strategic pivots across Irish business. Austrian bank Bawag entered exclusive talks to acquire Finance Ireland for up to €300 million — a deal that would hand a foreign lender a foothold in Irish car finance, SME lending, and mortgages. Meanwhile, two Irish-backed tech companies crossed the billion-dollar valuation threshold in the same week, and Diageo's new chief executive made his first major move by raising the price of Guinness by 7 cents a pint. The Business Post published 217 articles across the period, with Vish Gain (56 articles), Matthew Joyce (25), and Fionn Thompson (24) driving the bulk of the output.
By the Numbers
| Metric | Value | Signal |
|---|---|---|
| Finance Ireland acquisition value (est.) | €250–300m | M&A Active |
| Aikido Security valuation (post-raise) | $1bn | Unicorn |
| Project Eleven valuation (up from $28m) | $120m | +329% YoY |
| NTMA 2026 bond order book | €43bn | AA Rated |
| Diageo Guinness price hike (per pint, ex-VAT) | 7 cents | Cost Pressure |
| Deloitte 2026 insolvency forecast | 900 companies | Rising Risk |
| Logitech Ireland revenue growth (to Mar 2025) | +41% to €47.1m | Standout |
| Dublin residential transactions (Jan 1–14) | 257 | Market Active |
The Investigation
M&A, Funding & Deals: A Week of Concentrated Activity
Over the past seven days, the Business Post covered a remarkable concentration of deal activity across Irish business. The headline was Bawag's move on Finance Ireland — but beneath it, a pattern of Irish companies raising capital, acquiring targets, and expanding internationally was unmistakable. From a Limerick pharmacy software firm being absorbed by a Dublin PLC to a Monaghan healthtech startup attracting New York investment, the week showed Irish enterprise operating across multiple scales simultaneously.
| Story | Category | Value / Scale | Signal |
|---|---|---|---|
| Bawag acquires Finance Ireland | Banking M&A | €250–300m | Transformative |
| Aikido Security unicorn raise | Tech Funding | $60m / $1bn val. | Unicorn |
| Project Eleven hits $120m | Tech Funding | $120m val. (+329%) | Breakout |
| Uniphar acquires TouchStore | Pharma M&A | Undisclosed | Strategic |
| Nutritics backed by Kester Capital | FoodTech PE | £10–75m range | Growth |
| Spryt valued at €12.5m | HealthTech | €12.5m val. | Early Stage |
| NTMA €5bn bond raise | Sovereign Finance | €5bn / €43bn book | AA Rated |
| Deloitte: 900 insolvencies forecast | Insolvency Risk | 900 companies | Warning |
Sector Breakdown: Where the Stories Concentrated
The Business Post's 217 articles this week were distributed across sectors, with financial markets coverage dominating (driven by US bank earnings season) and Irish-specific stories concentrated in tech, banking, and legal beats.
Financial Performance: Notable Irish Companies in the News
Where financial data was disclosed or available from official filings, the picture is mixed: strong performers in tech and pharma distribution, with consumer-facing businesses under cost pressure.
| Company | Revenue / Valuation | Key Metric | Signal |
|---|---|---|---|
| Logitech Ireland Services Ltd | €47.1m (+41%) | 335 staff, avg wage €112,618 | Standout Growth |
| Uniphar PLC | €37.5m auth. capital | 8 directors, 3 subsidiaries | Active Acquirer |
| Aikido Security | $1bn valuation | 5x revenue growth, 100k+ teams | Unicorn |
| Project Eleven | $120m valuation | Up from $28m (329% growth) | Breakout |
| Spryt International Ltd | €12.5m valuation | 1.9m patients, Monaghan HQ | Early Stage |
| Grafton Group | £2.52bn (€2.91bn) revenue | +10.4% YoY (incl. acquisitions) | Cautious Outlook |
| Finance Ireland | €250–300m (deal value) | PIMCO 51%, M&G shareholders | Acquisition Target |
The Connections
Articles alone tell you what happened. Official records tell you who is behind it, how long they've been at it, and whether the public narrative matches the paper trail. This week, cross-referencing Business Post coverage against CRO filings, court records, and property data reveals connections that the headlines alone don't surface.
The Radar: Three Signals Worth Watching
The Deep Dive
Two companies this week warrant deeper investigation: one a 31-year-old Irish PLC quietly building a pharma empire through acquisition, the other a four-year-old Monaghan healthtech startup that has just attracted New York investment at a €12.5m valuation. Both tell a story about how Irish enterprise scales — and what the official record reveals that the headlines don't.
Uniphar Public Limited Company — The Quiet Consolidator
Uniphar Public Limited Company (CRO: 224324) was incorporated on 7 November 1994 at Citywest Business Park, Dublin. Founded by pharmacists to support the community pharmacy sector, it has grown into a multi-subsidiary pharma distribution and technology group. Its latest move — the acquisition of TouchStore, a Limerick-based pharmacy software firm with 35 staff — is consistent with a three-decade pattern of bolt-on acquisitions.
| Metric | Current | Notes |
|---|---|---|
| Company Type | PLC (Public Limited Company) | Listed on Euronext Dublin |
| Registration Date | 07/11/1994 | 31 years in operation |
| Authorised Capital | €37,536,424 | Significant balance sheet depth |
| Issued Capital | €20,765,944 | 55% of authorised issued |
| Active Directors | 8 | International board incl. USA, UK, Germany |
| Subsidiaries (CRO) | 3 confirmed | Medtech (47888), Pharma Solutions (728770), BD (739502) |
| Last Accounts Filed | 31/12/2024 | Auditor: AI223671 |
| TouchStore Acquisition | 2026 (terms undisclosed) | 35 staff, Limerick |
The question for 2026 accounts: will the TouchStore acquisition show up as a material asset addition, and will the European expansion strategy be reflected in revenue growth beyond the Irish market?
Spryt International Limited — Monaghan's AI Healthcare Startup
Spryt International Limited (CRO: 715833) was incorporated on 23 March 2022 at The Station House, Monaghan (eircode H18 YK54). The company has developed an AI receptionist called Asa that manages medical appointments through conversational AI, behavioural science, and predictive analytics. This week, it was valued at €12.5m following a strategic investment from MediDrive, a New York-based patient transportation company.
| Metric | Current | Notes |
|---|---|---|
| Registration Date | 23/03/2022 | 4 years old |
| Headquarters | The Station House, Monaghan | H18 YK54 |
| Issued Capital | €104,168 | Modest capital base for stage |
| Valuation (2026) | €12.5m | Post-MediDrive investment |
| Patients Supported | 1.9 million | UK NHS and private sector |
| Last Accounts Filed | 31/12/2024 | Annual return 23/09/2025 |
| Investor | MediDrive (New York) | Patient transportation services |
The question for 2026: can Spryt convert its 1.9 million patient base into a scalable revenue model, and will the MediDrive partnership accelerate its expansion into the US market?
Key People This Period
| Name | Role | Notable Activity | Connections |
|---|---|---|---|
| Dave Lewis | New CEO, Diageo | First major move: 7-cent Guinness price hike effective Feb 2; China asset review launched | Diageo price hike, China asset review |
| Sean Mulryan | Founder, Ballymore | 1,685-home London development approved by Newham Council; CRO confirms Ardenode Stud, Kildare base | Ballymore London |
| Billy Kane | CEO, Finance Ireland | Subject of €250-300m Bawag acquisition talks; Finance Ireland backed by PIMCO (51%) and M&G | Bawag deal |
| Finn Murphy | Co-founder, Project Eleven / Nebular VC | Project Eleven hits $120m valuation with Coinbase backing; formerly at Frontline VC Dublin | Project Eleven |
| Declan Kelly | Investor, Foreword Fund | Backed Aikido Security unicorn round via Foreword Fund; former Web Summit adviser | Aikido unicorn |
| Gerard Rabbette | Director, Uniphar PLC | Active director of Uniphar PLC since 01/03/2010; Foxrock, Dublin 18 | Uniphar PLC (224324), Uniphar Medtech (47888) |
| Stephen Holst | Managing Partner, McCann Fitzgerald | Re-elected for 3-year term (May 2026–April 2029); 21% partnership growth, 23% headcount growth under his tenure | McCann Fitzgerald |
| Paddy McKillen jnr | Property developer | Five receivership cases settled in High Court; Relm Finance (Paul Dowling) was lender; Interpath Advisory receivers | McKillen receivership |
One to Watch: Spryt International Limited
Spryt International Limited
| Metric | Value |
|---|---|
| Valuation (2026) | €12.5m |
| Patients Supported | 1.9 million |
| Issued Capital | €104,168 |
| Investor | MediDrive (New York) |
| Product | Asa AI receptionist |
| Last Accounts | 31/12/2024 |
Spryt International builds AI-powered appointment management tools for healthcare providers. Its product, Asa, automates booking, rescheduling, payment, and management of medical appointments through messaging channels, using conversational AI and predictive analytics to reduce no-shows and administrative burden.
Why it matters: Spryt is the overlooked story of the week. While the unicorn headlines went to Aikido Security and Project Eleven, a Monaghan-based healthtech startup quietly attracted New York investment at a €12.5m valuation. The MediDrive partnership — integrating AI appointment management with patient transportation — is a product bet that could scale Spryt's 1.9 million patient base into a US market entry. The CRO record shows a company registered in March 2022 with modest capital (€104,168 issued) but already filing accounts to December 2024 — a company that is operating, not just incorporated. The so-what: Spryt is building the infrastructure layer for healthcare access, not just a scheduling tool.
The number that matters: 1.9 million patients. That is not a startup metric — it is a market position. A company supporting 1.9 million patients from a Monaghan base, backed by a New York investor, is a company that has already crossed the proof-of-concept threshold. Watch for Spryt's 2025 accounts (due September 2026) to reveal whether the MediDrive investment is translating into revenue growth.
The Broader Picture
The Irish Courts
The High Court delivered 10 judgments in the week of 8–14 January 2026, with business-relevant cases spanning data protection, competition law, telecoms regulation, and energy sector disputes. The most significant for the corporate sector was the Meta DPC costs ruling — a procedural step in a multi-year battle that will shape how Ireland's data protection regime interacts with global tech companies. The Goode Concrete case, struck out after 16 years, is a cautionary tale about the cost of litigation delay.
| Citation | Parties | Subject | Why It Matters |
|---|---|---|---|
| [2026] IEHC 8 | Meta Platform Ireland v Data Protection Commission | Data protection costs ruling | Costs in the cause — ongoing DPC statutory appeals continue |
| [2026] IEHC 11 | Goode Concrete v CRH PLC & Ors | Competition case struck out | 16-year case ended for abuse of process; failure to pay costs |
| [2026] IEHC 12 | ComReg v Sky Ireland Limited | Telecoms regulatory enforcement | ComReg enforcement action against Sky Ireland — regulatory pressure on telecoms |
| [2026] IEHC 1 | San Leon Energy PLC v Brightwaters Energy Limited | Energy sector commercial dispute | Energy company litigation — sector under pressure from insolvency and restructuring |
| [2026] IEHC 3 | Graham v CPL Healthcare Limited | Employment / healthcare | Healthcare employment case — sector facing labour cost pressures |
Property Markets & Plans
The Dublin residential market opened 2026 with 257 transactions in the first two weeks of January, averaging €484,703 per property — a median of €445,000 that reflects a market still running well above the national average. The top transaction of the period was Glen House, Strawberry Beds, Chapelizod at €2.14m. On the commercial side, Kennedy Wilson received planning permission to redevelop the KPMG Dublin office at Stokes Place, while Eamon Waters' Sretaw Hotel Group secured approval for a 73-bed hotel near St Stephen's Green. Cushman & Wakefield's annual outlook described Ireland's real estate as at an “inflection point” — improving investment conditions but constrained by construction workforce shortages.
| Address | Amount | Date | Note |
|---|---|---|---|
| Glen House, Strawberry Beds, Chapelizod | €2,140,000 | 14 Jan 2026 | Highest Dublin transaction in period |
| 32 South Ave, Mount Merrion | €1,725,000 | 9 Jan 2026 | South Dublin premium residential |
| 36 Gilford Park, Sandymount, Dublin 4 | €1,620,000 | 9 Jan 2026 | Prime D4 location |
| 5 Merlyn Rd, Ballsbridge, Dublin 4 | €1,485,000 | 13 Jan 2026 | Ballsbridge premium |
| 43 Ashton Park, Monkstown, Blackrock | €1,200,000 | 9 Jan 2026 | South Dublin coastal |
The Week Ahead
The week of 8–14 January 2026 will be remembered as the week Ireland's dual-speed economy became impossible to ignore. On one track: a €300m banking acquisition, two tech unicorns, a €5bn sovereign bond oversubscribed 8.6x, and a Tyndall Institute doubling in size under a €100m semiconductor push. On the other: 900 insolvencies forecast, Guinness prices rising, pub closures accelerating, and a 16-year competition case struck out for failure to pay costs. The single most important takeaway: Ireland's institutional and corporate infrastructure is world-class, but the SME and hospitality sectors that employ the most people are under structural pressure that no amount of unicorn valuations will relieve.
What to Watch:
Watch for the Solar 21 creditor meeting outcome on February 3 — the first major insolvency test of 2026. Watch for Bawag regulatory clearance timelines and whether PTSB becomes a second target. Watch for Diageo's Q2 trading update to see whether the Guinness price hike is holding or being reversed under VFI pressure. And watch for Spryt International's 2025 accounts (due September 2026) — the first financial test of whether the MediDrive partnership is generating revenue, not just valuation.